3 takeaways from a European obesity scientific meeting
Published . Updated .
Eli Lilly impressed with its amylin-Zepbound combination data. Elsewhere, Novo demonstrated continued weight loss following a switch to oral and AbbVie and Boehringer gave glimpses into their contenders.
Directly affected
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Eli Lilly impressed with its amylin-Zepbound combination data. Elsewhere, Novo demonstrated continued weight loss following a switch to oral and AbbVie and Boehringer gave glimpses into their contenders.
Source: BioPharma Dive
Eli Lilly (LLY) since “3 takeaways from a European obesity scientific meeting,” compared with the market
Since the first closing price after “3 takeaways from a European obesity scientific meeting,” Eli Lilly (LLY) is +8.53%. The S&P 500 fund (SPY) is -0.40% over the same days, a +8.93% difference versus the market.
Filings that name Eli Lilly (LLY) around 1 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “3 takeaways from a European obesity scientific meeting”
Companies mentioned with this story
- LLY Eli Lilly
For “3 takeaways from a European obesity scientific meeting,” Eli Lilly (LLY) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names ELI LILLY & CO in the summary; GA resolved that company to LLY
How “3 takeaways from a European obesity scientific meeting” reaches Eli Lilly (LLY)
“3 takeaways from a European obesity scientific meeting” (1 Oct 2026) reaches Eli Lilly (LLY) through this story.
For Eli Lilly (LLY), the reason on file says The reported development directly names ELI LILLY & CO in the summary; GA resolved that company to LLY
The price range for Eli Lilly (LLY), and the dates in the story
LLY traded between 1131.55 and 1275.56 across 20 sessions. The latest close on file is 1240.65.
How solid “3 takeaways from a European obesity scientific meeting” looks
14 out of 100
“3 takeaways from a European obesity scientific meeting” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.